BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36907554)

  • 1. Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study.
    Marti-Marti I; Podlipnik S; Cañueto J; Ferrándiz-Pulido C; Deza G; Sanmartín O; Jaka A; Beà-Ardèbol S; Botella-Estrada R; Redondo P; Turrión-Merino L; Ruiz-Salas V; Masferrer E; Yébenes M; Sánchez-Schmidt JM; Gracia-Darder I; Altemir-Vidal A; Aguayo-Ortiz RS; Becerril S; Bodet-Castillo D; Leal L; Fuente MJ; Moreno-Arrones OM; Abril-Pérez C; Tomás-Velázquez A; Sandoval-Clavijo A; Toll A
    J Am Acad Dermatol; 2023 Jul; 89(1):119-127. PubMed ID: 36907554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.
    Smile TD; Ruiz ES; Kus KJB; Murad F; Wei W; Xiong DD; Vidimos AT; Schmults CD; Koyfman SA
    JAMA Dermatol; 2022 Apr; 158(4):390-394. PubMed ID: 35195668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease Progression in Cutaneous Squamous Cell Carcinoma Patients With Satellitosis and In-transit Metastasis.
    Smile TD; Xiong DX; Varra V; Winter IW; Beal BT; Gastman BR; Geiger JL; Adelstein DJ; Bergfeld WF; Piliang MP; Billings SD; Ko JS; Knackstedt TJ; Lucas JL; Poblete-Lopez CM; Meine JG; Vij A; Vidimos AT; Koyfman SA
    Anticancer Res; 2021 Jan; 41(1):289-295. PubMed ID: 33419823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.
    Schmults CD; Karia PS; Carter JB; Han J; Qureshi AA
    JAMA Dermatol; 2013 May; 149(5):541-7. PubMed ID: 23677079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis.
    Massey PR; Wang DM; Murad F; Mulvaney P; Moore K; Okhovat JP; Russell-Goldman E; Lin WM; Piris A; Huilgol SC; Ruiz ES; Schmults CD
    JAMA Dermatol; 2023 Dec; 159(12):1332-1338. PubMed ID: 37851425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
    Levine DE; Karia PS; Schmults CD
    JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
    Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
    JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma.
    Tejera-Vaquerizo A; García-Doval I; Llombart B; Cañueto J; Martorell-Calatayud A; Descalzo-Gallego MA; Sanmartín O
    J Dermatol; 2018 Jul; 45(7):781-790. PubMed ID: 29701281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma.
    Stevens JS; Murad F; Smile TD; O'Connor DM; Ilori E; Koyfman S; Vidimos A; Waldman AB; Ruiz ES
    JAMA Dermatol; 2023 Jul; 159(7):728-735. PubMed ID: 37285135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.
    Szewczyk M; Pazdrowski J; Golusiński P; Dańczak-Pazdrowska A; Marszałek S; Golusiński W
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3007-12. PubMed ID: 25217080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.
    Thompson AK; Kelley BF; Prokop LJ; Murad MH; Baum CL
    JAMA Dermatol; 2016 Apr; 152(4):419-28. PubMed ID: 26762219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prognostic prediction ability of the novel Japanese risk factor scoring system in a Japanese cohort of resectable cutaneous squamous cell carcinoma: A retrospective cross-sectional study.
    Doi R; Baba N; Kato H; Nakamura M; Matsushita S; Aoki M; Fujimoto N; Kato T; Iino S; Saito S; Yasuda M; Asai J; Ishikawa M; Yatsushiro H; Kawahara Y; Inafuku K; Matsuya T; Araki R; Teramoto Y; Hasegawa M; Nakama T; Nakamura Y
    Exp Dermatol; 2023 Oct; 32(10):1682-1693. PubMed ID: 37395158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
    Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.
    Metchnikoff C; Mully T; Singer JP; Golden JA; Arron ST
    J Am Acad Dermatol; 2012 Nov; 67(5):829-35. PubMed ID: 22285618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for incomplete excision of cutaneous squamous cell carcinoma: a large cohort study.
    Marsidi N; Ottevanger R; Bouwes Bavinck JN; Krekel-Taminiau NMA; Goeman JJ; Genders RE
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1229-1234. PubMed ID: 35342992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: Analysis of recurrence-free survival.
    Samsanavičius D; Kaikaris V; Norvydas SJ; Liubauskas R; Valiukevičienė S; Makštienė J; Maslauskas K; Rimdeika R
    Medicina (Kaunas); 2016; 52(5):276-282. PubMed ID: 27746117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcomes in primary squamous cell carcinoma of the auricle: a retrospective cohort analysis.
    Tanamal PJ; Geng CX; Nijhawan RI; Wynings E; Balachandra S; Myers LL; Tillman BN; Day AT
    Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):335-341. PubMed ID: 33956206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy.
    Xu MJ; Lazar AA; Garsa AA; Arron ST; Ryan WR; El-Sayed IH; George JR; Algazi AP; Heaton CM; Ha PK; Yom SS
    Head Neck; 2018 Jul; 40(7):1406-1414. PubMed ID: 29524273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Recurrence and Progression in Poorly Differentiated Cutaneous Squamous Cell Carcinomas: Insights from a Real-Life Experience.
    Roccuzzo G; Orlando G; Rumore MR; Morrone A; Fruttero E; Caliendo V; Picciotto F; Sciarrillo A; Quaglino P; Cassoni P; Ribero S; Senetta R
    Dermatology; 2024; 240(2):329-336. PubMed ID: 38008073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.